You are here: Home » Companies » News
Business Standard

Hindustan Unilever separates positions of Chairman and CEO & MD

Nitin Paranjpe appointed as non-executive chairman, Sanjiv Mehta to continue as CEO & MD

Topics
Hindustan Unilever | HUL | CEO

Sharleen D'Souza  |  Mumbai 

Nitin Paranjpe, Sanjiv Mehta
While Nitin Paranjpe (left) has been appointed non-executive chairman, Sanjiv Mehta will continue as the CEO & MD of HUL

(HUL) has separated the positions of chairman of the board and the chief executive officer & managing director ( & MD), which will be effective March 31.

The FMCG major has announced the appointment of Nitin Paranjpe, currently chief operating officer of Unilever, as the non-executive chairman of the company. Sanjiv Mehta will continue as & MD.

“The nomination & remuneration committee (NRC) of the board recommended his (Paranjpe) appointment to the board. The board accepted the recommendation made by the NRC and has appointed Paranjpe as a non-executive chairman. The appointment is subject to the approval of the shareholders, which the company will seek as per applicable regulations,” said in its release.

As announced by Unilever in January, Paranjpe will take on a new role as chief transformation officer & chief people officer, leading the business transformation and heading the HR function for Unilever effective April 2022. He is also a member of the Supervisory Board of Heineken NV.

Sanjiv Mehta, chairman & managing director of HUL, said: “We welcome Nitin back to as the non-executive chairman. He brings in huge knowledge and experience which will enrich the deliberations and add value to the board.”

Mehta also thanked the board for their support rendered to him during his tenure and added: “It has been an honour to have led the HUL board over the past few years.”

Paranjpe said: “I look forward to working closely with Sanjiv and the board to further strengthen the company and help navigate the challenges and opportunities in the years ahead.”

This move by HUL comes despite the capital market regulator, Securities and Exchange Board of India (SEBI), not making it mandatory for listed to split the position of chairperson and & MD positions.

SEBI had earlier asked listed entities to split the roles of chairperson and MD before the April 2022 deadline. Listed entities were initially required to separate the roles of chairperson and MD & CEO from April 1, 2020. However, based on industry representations, an additional time period of two years was given for compliance. The norms were part of the series of recommendations given by the Sebi-appointed Uday Kotak committee on corporate governance.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, February 24 2022. 15:06 IST
RECOMMENDED FOR YOU
.